Best Practice & Research Clinical Haematology
Volume 21, Issue 1 , Pages 85-92, March 2008

Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML)

  • Frederick R. Appelbaum, MD (Director of the Clinical Research Division, Head of the Division of Oncology)

      Affiliations

    • Corresponding Author InformationTel.: +1 206 667 4412; Fax: +1 206 667 6936.

Fred Hutchinson Cancer Research Center, Clinical Research Division, 1100 Fairview Avenue North, D5-310, P.O. Box 19024, Seattle, WA 98109-1024, USA

Division of Oncology, University of Washington, Seattle, WA, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(07)00102-8

doi:10.1016/j.beha.2007.11.013

Best Practice & Research Clinical Haematology
Volume 21, Issue 1 , Pages 85-92, March 2008

Article Tools

* Image Usage & Resolution